{
    "SPADE_UN_13832": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_13832",
            "Peptide Name": "MERS-CoV-HR2P [T1263E,L1267R]",
            "Source": "Synthetic construct",
            "Family": "Coronaviridae",
            "Gene": "Not found",
            "Sequence": "SLTQINTTLLDLEYEMRSLQQVVKALNESYIDLKEL",
            "Sequence Length": 36,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/K9N5Q8"
            ],
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Antiviral"
            ],
            "Target Organism": "[Ref.24473083]MERS-COV(Middle East respiratory syndrome coronavirus):inhibition of cell–cell fusion infection in Huh-7 and 293T/MERS/EGFP cells (IC50=0.93±0.15µM); inhibition of MERS-CoV infection in Vero cells (IC50=0.6µM); inhibition of MERS-CoV infection in Calu-3 cells (IC50=0.6µM); inhibition of MERS-CoV infection in HFL cells (IC50=13.9µM).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "[Ref.24473083]HR2P has low or no in vitro toxic effect.",
            "Binding Target": "HR1 domain",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C186H308N46O62S",
            "Mass": 4212.77,
            "PI": 4.36,
            "Net Charge": -3,
            "Hydrophobicity": -0.18,
            "Half Life": "Mammalian:1.9 hourYeast:>20 hourE.coli:>10 hour",
            "Mechanism of action": "interact with the viral HR1 domain to form heterologous 6-HB and block viral fusion coreformation, resulting in inhibition of MERS-CoV S protein-mediated membrane fusion.",
            "Literature": [
                {
                    "Title": "Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor.",
                    "Pubmed ID": "24473083",
                    "Reference": "Nat Commun. 2014;53067.",
                    "Author": "Lu L, Liu Q, Zhu Y, Chan KH, Qin L, Li Y, Wang Q, Chan JF, Du L, Yu F, Ma C, Ye S, Yuen KY, Zhang R, Jiang S.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=24473083"
                }
            ],
            "Frequent Amino Acids": "LEQ",
            "Absent Amino Acids": "CFGHOPUW",
            "Basic Residues": 3,
            "Acidic Residues": 6,
            "Hydrophobic Residues": 16,
            "Polar Residues": 19,
            "Positive Residues": 3,
            "Negative Residues": 6,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_14239",
                    "Similarity": 1.0,
                    "Sequence": "LDLYEMSLQQVVKALNESY"
                },
                {
                    "SPADE_ID": "SPADE_UN_14241",
                    "Similarity": 0.9473684210526315,
                    "Sequence": "LDLTYEMSLQVVKALNESY"
                },
                {
                    "SPADE_ID": "SPADE_UN_13541",
                    "Similarity": 0.9444444444444444,
                    "Sequence": "SLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKELGSGSGC"
                }
            ]
        }
    }
}